Literature DB >> 20021373

Tau as a molecular marker of development, aging and neurodegenerative disorders.

Félix Hernández1, Mar Pérez, Elena Gómez de Barreda, Paloma Goñi-Oliver, Jesús Avila.   

Abstract

The purpose of this work is to review the changes that take place in the microtubule associated protein tau during neuronal development, aging and neurodegeneration. Human tau protein is expressed from a single gene located on chromosome 17. The DNA is transcribed into nuclear RNA and this RNA, by alternative splicing, yields different mRNA species which are developmentally regulated. In aging, or in neurodegenerative disorders, post translational modifications of tau, such as phosphorylation, could take place, and new tau isoforms may appear. Thus, tau isoforms can be used as markers to follow neuronal development, aging or neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 20021373     DOI: 10.2174/1874609810801010056

Source DB:  PubMed          Journal:  Curr Aging Sci        ISSN: 1874-6098


  9 in total

Review 1.  Modeling simple repeat expansion diseases with iPSC technology.

Authors:  Edyta Jaworska; Emilia Kozlowska; Pawel M Switonski; Wlodzimierz J Krzyzosiak
Journal:  Cell Mol Life Sci       Date:  2016-06-03       Impact factor: 9.261

2.  Differences in Tau Seeding in Newborn and Adult Wild-Type Mice.

Authors:  Isidro Ferrer; Pol Andrés-Benito; Paula Garcia-Esparcia; Irene López-Gonzalez; Diego Valiente; Mónica Jordán-Pirla; Margarita Carmona; Julia Sala-Jarque; Vanessa Gil; José Antonio Del Rio
Journal:  Int J Mol Sci       Date:  2022-04-26       Impact factor: 6.208

3.  Microtubule-associated protein tau in bovine retinal photoreceptor rod outer segments: comparison with brain tau.

Authors:  Akio Yamazaki; Yuji Nishizawa; Isao Matsuura; Fumio Hayashi; Jiro Usukura; Vladimir A Bondarenko
Journal:  Biochim Biophys Acta       Date:  2013-05-24

4.  The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases.

Authors:  D K Lahiri; B Maloney; N H Zawia
Journal:  Mol Psychiatry       Date:  2009-11       Impact factor: 15.992

5.  Dysregulated coordination of MAPT exon 2 and exon 10 splicing underlies different tau pathologies in PSP and AD.

Authors:  Kathryn R Bowles; Derian A Pugh; Laura-Maria Oja; Benjamin M Jadow; Kurt Farrell; Kristen Whitney; Abhijeet Sharma; Jonathan D Cherry; Towfique Raj; Ana C Pereira; John F Crary; Alison M Goate
Journal:  Acta Neuropathol       Date:  2021-12-07       Impact factor: 17.088

6.  Expression of 1N3R-Tau isoform inhibits cell proliferation by inducing S phase arrest in N2a cells.

Authors:  Li Li; Zhi-Peng Xu; Gong-Ping Liu; Cheng Xu; Zhi-Hao Wang; Xiao-Guang Li; En-Jie Liu; Juan Zeng; Da-Min Chai; Wen-Long Yao; Jian-Zhi Wang
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

Review 7.  Cognitive Decline in Neuronal Aging and Alzheimer's Disease: Role of NMDA Receptors and Associated Proteins.

Authors:  Jesús Avila; María Llorens-Martín; Noemí Pallas-Bazarra; Marta Bolós; Juan R Perea; Alberto Rodríguez-Matellán; Félix Hernández
Journal:  Front Neurosci       Date:  2017-11-10       Impact factor: 4.677

8.  Physiological characterisation of human iPS-derived dopaminergic neurons.

Authors:  Elizabeth M Hartfield; Michiko Yamasaki-Mann; Hugo J Ribeiro Fernandes; Jane Vowles; William S James; Sally A Cowley; Richard Wade-Martins
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

Review 9.  Cyclin-dependent kinase 5, a node protein in diminished tauopathy: a systems biology approach.

Authors:  John F Castro-Alvarez; S Alejandro Uribe-Arias; Daniel Mejía-Raigosa; Gloria P Cardona-Gómez
Journal:  Front Aging Neurosci       Date:  2014-09-01       Impact factor: 5.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.